Влияние курения на сексуальную функцию у мужчин
Урология
Дата публикации: декабря 20, 2014
Ключевые слова
эректильная дисфункция
курение
артериогенная эректильная дисфункция
курение
артериогенная эректильная дисфункция
Как цитировать
[1]
С. Гамидов, Р. Овчинников, Д. Щербаков, и Р. Коротеев, Влияние курения на сексуальную функцию у мужчин, КМКВ, вып. 2, сс. 34-37, дек. 2014.
Аннотация
Обзор научных публикаций о влиянии курения насексуальную функцию мужчин.Ключевые слова: эректильная дисфункция, курение,артериогенная эректильная дисфункция.Smoking effect on the male sexual functionGamidov S.I, Ovchinnikov R.I., Sherbakov D.V.,Koroteyev R.V.«Сlinical hospital» of the Department of affairs managementof President of Russian Federation, MoscowPirogov’s Russian State Medical University, MoscowSummarySurvey of scientific publications about the influence ofsmoking on the sexual function of men.Key words: smoking, sexual function, the erectile dysfunction.Литература
1. Tostes R.C., Carneiro F.S., Lee A.J., Giachini F.R., Leite R.,
Osawa Y., Webb R.C. Cigarette Smoking and Erectile Dysfunction:
Focus on NO Bioavailability and ROS Generation. J. Sex
Med.2008.
2. Dishy V., Harris P.A., Pierce R et al. Sildenafil does not improve
nitric oxide-mediated endothelium-dependent vascular responses in
smokers // Br J Clin Pharmacol. – 2004. – Vol. 57. – P. 209–212.
3. Millett C.; Wen L.M.; Rissel C.; Smith A.; Richters J.;
Grulich A.; de Visser R. Smoking and erectile dysfunction: findings
from a representative sample of Australian men. Tob Control. 2006;
15(2):136-9.
4. Austoni E.; Mirone V.; Parazzini F.; Fasolo C.B.; Turchi P.;
Pescatori E.S.; Ricci E.; Gentile V.; Smoking as a risk factor for
erectile dysfunction: data from the Andrology Prevention Weeks
2001-2002 a study of the Italian Society of Andrology.Eur Urol.
2005; 48(5):810-7; discussion 817-8.
5. McVary K.T.; Carrier S.; Wessells H.; Smoking and erectile
dysfunction: evidence based analysis,J Urol. 2001; 166(5):1624-32.
6. Corona G.; Mannucci E.; Petrone L.; Ricca V.; Mansani R.;
Cilotti A.; Balercia G.; Chiarini V.; Giommi R.; Forti G.; Maggi
M. Psychobiological correlates of smoking in patients with erectile
dysfunction. Int J Impot Res. 2005; 17(6):527-34.
7. Shiri R.; Hakkinen J.; Koskimaki J.; Tammela T.L.; Auvinen
A.; Hakama M. Smoking causes erectile dysfunction through
vascular disease.Urology. 2006; 68(6):1318-22 .
8. Guay A.T.; Perez J.B.; Heatley G.J. Cessation of smoking
rapidly decreases erectile dysfunction. Endocr Pract. 1998; 4(1):23-6
9. McMahon C.G., Touma K. Predictive value of patient
history and correlation of nocturnal penile tumescence, colour
duplex Doppler ultrasonography and dynamic cavernosometry and
cavernosography in the evaluation of erectile dysfunction Int J Impot
Res. 1999;11(1):47-51.
10. Hirshkowitz M., Karacan I., Howell J.W., et al. Nocturnal
penile tumescence in cigarette smokers with erectile dysfunction
Urology. 1992;39(2):101-107.
11. Rosen M.P., Greenfield A.J., Walker T.G., et al. Cigarette
smoking: an independent risk factor for atherosclerosis in the
hypogastric-cavernous arterial bed of men with arteriogenic
impotence. J Urol. 1991;145(4):759-763.
12. Xie Y., Garban H., Ng C., et al. Effects of long-term passive
smoking on erectile function and penile nitric oxide synthase in the
rat. J Urol. 1997;157(3):1121-1126.
13. Levine L.A., Gerber G.S.. Acute vasospasm of penile arteries
in response to cigarette smoking. Urology. 1990;36(1):99-100.
14. Aoki M., Kumamoto Y. Analyses of factors contributing to
the erectile dysfunction with aging by nocturnal penile tumescence,
penile blood pressure index and papaverine test [in Japanese].
Nippon Hinyokika Gakkai Zasshi. 1990;81(11):1633-1641.
15. Derby C.A., Mohr B.A., Goldstein I., et al. Modifiable risk
factors and erectile dysfunction: can lifestyle changes modify risk?
Urology. 2000; 56(2):302-306.
16. Imamura M., Waseda Y., Marinova G.V., Ishibashi T.,
Obayashi S., Sasaki A., Nagai A., Azuma H. Alterations of NOS,
arginase and DDAH proteins expression in the rabbit cavernous
tissue following administration of cigarette smoke extract. Am J
Physiol Regul Integr Comp Physiol. 2007.
17. He J, Reynolds K, Chen J, Chen CS, Wu X, Duan X, Reynolds
R, Bazzano LA, Whelton PK, Gu D. Cigarette smoking and erectile
dysfunction among Chinese men without clinical vascular disease.
Am J Epidemiol. 2007;166(7):803-9.
18) Sighinolfi M.C., Mofferdin A., De Stefani S., Micali
S., Cicero A.F., Bianchi G. Immediate improvement in penile
hemodynamics after cessation of smoking: previous results. Urology.
2007 Jan;69(1):163-5.
19. Hanna S.T.. Nicotine effect on cardiovascular system and ion
channels. J Cardiovasc Pharmacol. 2006;47(3):348-58.
20. Gades N.M., Nehra A., Jacobson D.J., McGree M.E.,
Girman C.J., Rhodes T., Roberts R.O., Lieber M.M., Jacobsen S.J.
Association between smoking and erectile dysfunction: a populationbased
study. Am J Epidemiol. 2005;161(4):346-51.
21. Kupelian V., Link C.L., McKinlay J.B. Association between
smoking, passive smoking, and erectile dysfunction: results from the
Boston Area Community Health (BACH) Survey. Eur Urol. 2007
Aug;52(2):416-22.
22. Gulec M., Bakir B., Ozer M., Ucar M., Kilic S., Hasde M.
Association between cigarette smoking and depressive symptoms
among military medical students in Turkey. Psychiatry Res. 2005
Apr 30;134(3):281-6.
23. Park K., Ku J.H., Kim S.W., Paick J.S.. Risk factors in
predicting a poor response to sildenafil citrate in elderly men with
erectile dysfunction BJU Int. 2005;95(3):366-70.
24. Pourmand G., Alidaee M.R., Rasuli S., Maleki A., Mehrsai
A. Do cigarette smokers with erectile dysfunction benefit from
stopping?: a prospective study. BJU Int. 2004:1310-3.
25. Elhanbly S., Abdel-Gaber S., Fathy H., El-Bayoumi Y, Wald
M., Niederberger C.S. Erectile dysfunction in smokers: a penile
dynamic and vascular study. J Androl. 2004:991-5
26) Stanley L. Hazen, Marie-Luise Brennan, Marc S. Penn,
Frederick Van Lente. Prognostic Value of Myeloperoxidase in
Patients with Chest Pain New England Journal of Medicine vol. 349
no. 17(2003).
27. Feldman H.A., Goldstein I., Hatzichristou D.G. et al.
Impotence and its medical and psychological correlates: results of
the Massachusetts Male Aging Study. // J Urol – 1994 – Vol. 151
– P. 54–61.
28. Braun M., Wassner G., Klotz T et al. Epidemiology of erectile
dysfunction: results of the “Cologne Male Survey”. // Int J Impot
Res – 2000 – Vol. 12 – P. 305–311.
29. Chew K.K., Earle C.M., Stuckey B.G.A. et al. Erectile
dysfunction in general medicine practice: prevalence and clinical
correlates. // Int J Impot Res – 2000 – Vol. 12 – P. 41–5.
30. Martin-Morales A., Sanchez-Cruz J.J., Saenz de Tejada I et
al. Prevalence and independent risk factors for erectile dysfunction
in Spain: results of the Epidemiologia de la Disfunction Erectil
Masculina Study. // J Urol – 2001 – Vol. 166 – P. 569–575
31. Parazzini F., Menchini F.F., Bortolotti A. et. al. Frequency
and determinants of erectile dysfunction in Italy. // Eur Urol – 2000
– Vol. 37 – P. 43–49.
32. Roumeguere T., Wespes E., Carpentier Y. et. al. Erectile
dysfunction is associated with a high prevalence of hyperlipidemia
and coronary heart disease risk. // Eur Urol – 2003 – Vol. 44 – P.
355–359.
33. Ponholzer A., Temml C., Mock K et al. Prevalence and
risk factors for erectile dysfunction in 2869 men using a validated
questionnaire. // Eur Urol. – 2005 – Vol. 47 – P. 80–85
34. Shabsigh R, Fishman IJ, Schum C et al. Cigarette smoking
and other vascular risk factors in vasculogenic impotence. // Urology
– 1991 – Vol. 38 – P. 227–232.
35. Shabsigh R., Perelman M.A., Lockhart DC et al. Health
issues of men: prevalence and correlates of erectile dysfunction. // J
Urol. – 2005 – Vol. 174 – P. 662–667.
36. Melman A., Gingell J.C. The epidemiology and
pathophysiology of erectile dysfunction. // J Urol – 1999 – Vol. 161
– P. 5–11.
37. Ayta I.A. et al. [Ayta I.A., McKinlay J.B., Krane R.J. The
likely worldwide increase in erectile dysfunction between 1995 and
2025 and some possible policy consequences. BJU Int 1999; 84:50-
56.
38. Laumann E. O., Paik A., Rosen R. C. The epidemiology of
erectile dysfunction: results from the National Health and Social
Life Survey. Int J ImpotRes 1999; 11 (Suppl.l): S. 60–64.
39. Celermajer DS., Sorensen KE,. Georgakopoulos D., et al.
Cigarette smoking is associated with dose–related and potentially
reversible impairment of endothelium–dependent dilation in healthy
young adults. Circulation. 1993;88:2149–2155.
40. Roxana Campisi, Johannes Czernin, Heiko Schoder, James
W. Sayre, Heinrich R. Schelbert L–Arginine Normalizes Coronary
Vasomotion in Long–Term Smokers Circulation. 1999; 99:491–497
41. Zhonghua Nan Ke Xue. Yang H, Wang DW, Shuang WB,
Wang JQ, Zhang L, Zhao B, Zhang J.[Expression of P-selectin in the
penile vascular epithelia of smoking rats] 2008:1094-8. Department
of Urology, The First Hospital of Shanxi Medical University,
Taiyuan.
42. Bivalacqua T.J., Sussan T.E., Gebska M.A., Strong T.D.,
Berkowitz D.E., Biswal S., Burnett A.L., Champion H.C. Sildenafil
inhibits superoxide formation and prevents endothelial dysfunction
in a mouse model of secondhand smoke induced erectile dysfunction.
//J Urol. 2009;181(2):899-906.
43. Chew K.K., Bremner A., Stuckey B., Earle C., Jamrozik
K. Is the relationship between cigarette smoking and male erectile
dysfunction independent of cardiovascular disease? Findings
from a population-based cross-sectional study. J Sex Med. 2009
Jan;6(1):222-31.
Osawa Y., Webb R.C. Cigarette Smoking and Erectile Dysfunction:
Focus on NO Bioavailability and ROS Generation. J. Sex
Med.2008.
2. Dishy V., Harris P.A., Pierce R et al. Sildenafil does not improve
nitric oxide-mediated endothelium-dependent vascular responses in
smokers // Br J Clin Pharmacol. – 2004. – Vol. 57. – P. 209–212.
3. Millett C.; Wen L.M.; Rissel C.; Smith A.; Richters J.;
Grulich A.; de Visser R. Smoking and erectile dysfunction: findings
from a representative sample of Australian men. Tob Control. 2006;
15(2):136-9.
4. Austoni E.; Mirone V.; Parazzini F.; Fasolo C.B.; Turchi P.;
Pescatori E.S.; Ricci E.; Gentile V.; Smoking as a risk factor for
erectile dysfunction: data from the Andrology Prevention Weeks
2001-2002 a study of the Italian Society of Andrology.Eur Urol.
2005; 48(5):810-7; discussion 817-8.
5. McVary K.T.; Carrier S.; Wessells H.; Smoking and erectile
dysfunction: evidence based analysis,J Urol. 2001; 166(5):1624-32.
6. Corona G.; Mannucci E.; Petrone L.; Ricca V.; Mansani R.;
Cilotti A.; Balercia G.; Chiarini V.; Giommi R.; Forti G.; Maggi
M. Psychobiological correlates of smoking in patients with erectile
dysfunction. Int J Impot Res. 2005; 17(6):527-34.
7. Shiri R.; Hakkinen J.; Koskimaki J.; Tammela T.L.; Auvinen
A.; Hakama M. Smoking causes erectile dysfunction through
vascular disease.Urology. 2006; 68(6):1318-22 .
8. Guay A.T.; Perez J.B.; Heatley G.J. Cessation of smoking
rapidly decreases erectile dysfunction. Endocr Pract. 1998; 4(1):23-6
9. McMahon C.G., Touma K. Predictive value of patient
history and correlation of nocturnal penile tumescence, colour
duplex Doppler ultrasonography and dynamic cavernosometry and
cavernosography in the evaluation of erectile dysfunction Int J Impot
Res. 1999;11(1):47-51.
10. Hirshkowitz M., Karacan I., Howell J.W., et al. Nocturnal
penile tumescence in cigarette smokers with erectile dysfunction
Urology. 1992;39(2):101-107.
11. Rosen M.P., Greenfield A.J., Walker T.G., et al. Cigarette
smoking: an independent risk factor for atherosclerosis in the
hypogastric-cavernous arterial bed of men with arteriogenic
impotence. J Urol. 1991;145(4):759-763.
12. Xie Y., Garban H., Ng C., et al. Effects of long-term passive
smoking on erectile function and penile nitric oxide synthase in the
rat. J Urol. 1997;157(3):1121-1126.
13. Levine L.A., Gerber G.S.. Acute vasospasm of penile arteries
in response to cigarette smoking. Urology. 1990;36(1):99-100.
14. Aoki M., Kumamoto Y. Analyses of factors contributing to
the erectile dysfunction with aging by nocturnal penile tumescence,
penile blood pressure index and papaverine test [in Japanese].
Nippon Hinyokika Gakkai Zasshi. 1990;81(11):1633-1641.
15. Derby C.A., Mohr B.A., Goldstein I., et al. Modifiable risk
factors and erectile dysfunction: can lifestyle changes modify risk?
Urology. 2000; 56(2):302-306.
16. Imamura M., Waseda Y., Marinova G.V., Ishibashi T.,
Obayashi S., Sasaki A., Nagai A., Azuma H. Alterations of NOS,
arginase and DDAH proteins expression in the rabbit cavernous
tissue following administration of cigarette smoke extract. Am J
Physiol Regul Integr Comp Physiol. 2007.
17. He J, Reynolds K, Chen J, Chen CS, Wu X, Duan X, Reynolds
R, Bazzano LA, Whelton PK, Gu D. Cigarette smoking and erectile
dysfunction among Chinese men without clinical vascular disease.
Am J Epidemiol. 2007;166(7):803-9.
18) Sighinolfi M.C., Mofferdin A., De Stefani S., Micali
S., Cicero A.F., Bianchi G. Immediate improvement in penile
hemodynamics after cessation of smoking: previous results. Urology.
2007 Jan;69(1):163-5.
19. Hanna S.T.. Nicotine effect on cardiovascular system and ion
channels. J Cardiovasc Pharmacol. 2006;47(3):348-58.
20. Gades N.M., Nehra A., Jacobson D.J., McGree M.E.,
Girman C.J., Rhodes T., Roberts R.O., Lieber M.M., Jacobsen S.J.
Association between smoking and erectile dysfunction: a populationbased
study. Am J Epidemiol. 2005;161(4):346-51.
21. Kupelian V., Link C.L., McKinlay J.B. Association between
smoking, passive smoking, and erectile dysfunction: results from the
Boston Area Community Health (BACH) Survey. Eur Urol. 2007
Aug;52(2):416-22.
22. Gulec M., Bakir B., Ozer M., Ucar M., Kilic S., Hasde M.
Association between cigarette smoking and depressive symptoms
among military medical students in Turkey. Psychiatry Res. 2005
Apr 30;134(3):281-6.
23. Park K., Ku J.H., Kim S.W., Paick J.S.. Risk factors in
predicting a poor response to sildenafil citrate in elderly men with
erectile dysfunction BJU Int. 2005;95(3):366-70.
24. Pourmand G., Alidaee M.R., Rasuli S., Maleki A., Mehrsai
A. Do cigarette smokers with erectile dysfunction benefit from
stopping?: a prospective study. BJU Int. 2004:1310-3.
25. Elhanbly S., Abdel-Gaber S., Fathy H., El-Bayoumi Y, Wald
M., Niederberger C.S. Erectile dysfunction in smokers: a penile
dynamic and vascular study. J Androl. 2004:991-5
26) Stanley L. Hazen, Marie-Luise Brennan, Marc S. Penn,
Frederick Van Lente. Prognostic Value of Myeloperoxidase in
Patients with Chest Pain New England Journal of Medicine vol. 349
no. 17(2003).
27. Feldman H.A., Goldstein I., Hatzichristou D.G. et al.
Impotence and its medical and psychological correlates: results of
the Massachusetts Male Aging Study. // J Urol – 1994 – Vol. 151
– P. 54–61.
28. Braun M., Wassner G., Klotz T et al. Epidemiology of erectile
dysfunction: results of the “Cologne Male Survey”. // Int J Impot
Res – 2000 – Vol. 12 – P. 305–311.
29. Chew K.K., Earle C.M., Stuckey B.G.A. et al. Erectile
dysfunction in general medicine practice: prevalence and clinical
correlates. // Int J Impot Res – 2000 – Vol. 12 – P. 41–5.
30. Martin-Morales A., Sanchez-Cruz J.J., Saenz de Tejada I et
al. Prevalence and independent risk factors for erectile dysfunction
in Spain: results of the Epidemiologia de la Disfunction Erectil
Masculina Study. // J Urol – 2001 – Vol. 166 – P. 569–575
31. Parazzini F., Menchini F.F., Bortolotti A. et. al. Frequency
and determinants of erectile dysfunction in Italy. // Eur Urol – 2000
– Vol. 37 – P. 43–49.
32. Roumeguere T., Wespes E., Carpentier Y. et. al. Erectile
dysfunction is associated with a high prevalence of hyperlipidemia
and coronary heart disease risk. // Eur Urol – 2003 – Vol. 44 – P.
355–359.
33. Ponholzer A., Temml C., Mock K et al. Prevalence and
risk factors for erectile dysfunction in 2869 men using a validated
questionnaire. // Eur Urol. – 2005 – Vol. 47 – P. 80–85
34. Shabsigh R, Fishman IJ, Schum C et al. Cigarette smoking
and other vascular risk factors in vasculogenic impotence. // Urology
– 1991 – Vol. 38 – P. 227–232.
35. Shabsigh R., Perelman M.A., Lockhart DC et al. Health
issues of men: prevalence and correlates of erectile dysfunction. // J
Urol. – 2005 – Vol. 174 – P. 662–667.
36. Melman A., Gingell J.C. The epidemiology and
pathophysiology of erectile dysfunction. // J Urol – 1999 – Vol. 161
– P. 5–11.
37. Ayta I.A. et al. [Ayta I.A., McKinlay J.B., Krane R.J. The
likely worldwide increase in erectile dysfunction between 1995 and
2025 and some possible policy consequences. BJU Int 1999; 84:50-
56.
38. Laumann E. O., Paik A., Rosen R. C. The epidemiology of
erectile dysfunction: results from the National Health and Social
Life Survey. Int J ImpotRes 1999; 11 (Suppl.l): S. 60–64.
39. Celermajer DS., Sorensen KE,. Georgakopoulos D., et al.
Cigarette smoking is associated with dose–related and potentially
reversible impairment of endothelium–dependent dilation in healthy
young adults. Circulation. 1993;88:2149–2155.
40. Roxana Campisi, Johannes Czernin, Heiko Schoder, James
W. Sayre, Heinrich R. Schelbert L–Arginine Normalizes Coronary
Vasomotion in Long–Term Smokers Circulation. 1999; 99:491–497
41. Zhonghua Nan Ke Xue. Yang H, Wang DW, Shuang WB,
Wang JQ, Zhang L, Zhao B, Zhang J.[Expression of P-selectin in the
penile vascular epithelia of smoking rats] 2008:1094-8. Department
of Urology, The First Hospital of Shanxi Medical University,
Taiyuan.
42. Bivalacqua T.J., Sussan T.E., Gebska M.A., Strong T.D.,
Berkowitz D.E., Biswal S., Burnett A.L., Champion H.C. Sildenafil
inhibits superoxide formation and prevents endothelial dysfunction
in a mouse model of secondhand smoke induced erectile dysfunction.
//J Urol. 2009;181(2):899-906.
43. Chew K.K., Bremner A., Stuckey B., Earle C., Jamrozik
K. Is the relationship between cigarette smoking and male erectile
dysfunction independent of cardiovascular disease? Findings
from a population-based cross-sectional study. J Sex Med. 2009
Jan;6(1):222-31.